iifl-logo-icon 1

Balaxi Pharmaceuticals Ltd Share Price

105.25
(-1.52%)
Jul 22, 2024|02:04:57 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open111.65
  • Day's High111.68
  • 52 Wk High151.45
  • Prev. Close106.87
  • Day's Low104.63
  • 52 Wk Low79.99
  • Turnover (lac)31.74
  • P/E161.92
  • Face Value2
  • Book Value22.51
  • EPS0.66
  • Mkt. Cap (Cr.)581.06
  • Div. Yield0
No Records Found

Balaxi Pharmaceuticals Ltd KEY RATIOS

Sector

Trading

Open

111.65

Prev. Close

106.87

Turnover(Lac.)

31.74

Day's High

111.68

Day's Low

104.63

52 Week's High

151.45

52 Week's Low

79.99

Book Value

22.51

Face Value

2

Mkt Cap (₹ Cr.)

581.06

P/E

161.92

EPS

0.66

Divi. Yield

0

Balaxi Pharmaceuticals Ltd Corporate Action

13 Jul 2023

12:00 AM

AGM

Announcement Date: 13 Jul, 2023

arrow

21 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

28 Feb 2024

12:00 AM

Split

arrow

Balaxi Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Balaxi Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:26 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 66.35%

Foreign: 0.00%

Indian: 66.35%

Non-Promoter- 17.10%

Institutions: 17.10%

Non-Institutions: 16.54%

Custodian: 0.00%

Share Price

Balaxi Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

20.48

10

10

10

Preference Capital

0

0

0

0

Reserves

71.63

47.91

33.25

18.11

Net Worth

92.11

57.91

43.25

28.11

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

101.29

86.87

45.63

0

yoy growth (%)

16.59

90.37

0

0

Raw materials

-76.91

-63.32

-33.57

0

As % of sales

75.93

72.89

73.58

0

Employee costs

-2.89

-1.94

-1.76

-0.15

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

19.69

20.59

9.26

-0.76

Depreciation

-0.25

-0.08

0

0

Tax paid

-5.03

-5.46

-2.76

0

Working capital

5.53

-0.38

25.39

-0.78

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

16.59

90.37

0

0

Op profit growth

-8.6

192.29

-941.06

471.3

EBIT growth

-4.12

122.43

-1,303.49

478.82

Net profit growth

-3.07

132.97

-943.73

341.95

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

241.29

336.43

279.39

231.33

45.63

Excise Duty

0

0

0

0

0

Net Sales

241.29

336.43

279.39

231.33

45.63

Other Operating Income

0

0

0

0

0

Other Income

-2.65

2.64

4.97

2.23

0.59

Balaxi Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Adani Enterprises Ltd

ADANIENT

3,005.7

122.73,42,690.04776.710.049,210.18145.96

Aegis Logistics Ltd

AEGISLOG

854.4

73.8829,977.16125.880.38721.5167.87

Cello World Ltd

CELLO

940.55

334.8220,781.9718.620.15260.7765.65

Redington Ltd

REDINGTON

199.03

14.9415,541.68160.573.1210,490.2446.35

Honasa Consumer Ltd

HONASA

462.35

123.2814,910.3726.710427.1734.67

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Balaxi Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

Ashish Maheshwari

Non Executive Director

Minoshi Maheshwari

Independent Non Exe. Director

Kunal M Bhakta

Independent Non Exe. Director

Gandhi Gamji

Independent Non Exe. Director

M. Srinivas Rao

Independent Non Exe. Director

Purnima Singh Kamble

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Balaxi Ventures Limited (erstwhile known as The Anandam Rubber Company Limited) is a public limited company incorporated in India in September 28, 1942 with a basic objective of running rubber and tea plantations and owns several plantations across South India. In the year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading. The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products Securities and Exchange Board of India (SEBI) vide Circular dated May 30, 2012 had issued revised Exit Policy for de-recognized/non-operational stock exchanges. Pursuant to the circular, Madras Stock Exchange has been de-recognized by SEBI, recently. Further, as per above cited circular issued by SEBI on May 30, 2012, and Public Notice issued by Madras Stock Exchange Limited (MSE), it cleared that the Exclusively Listed Companies, which fail to obtain listing on any other stock exchange, will cease to be a listed company and will be moved to the Dissemination Board by the exiting stock exchange. Also, it is to be noted that SEBI has given a time limit of eighteen months for getting listed with any of the recognized stock exchanges. In pursuance to the above notice, the company has submitted listing application with National Stock Exchange of India (NSE) Limited
Read More

Company FAQs

What is the Balaxi Pharmaceuticals Ltd share price today?

Down Arrow

The Balaxi Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹105.25 today.

What is the Market Cap of Balaxi Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Balaxi Pharmaceuticals Ltd is ₹581.06 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Balaxi Pharmaceuticals Ltd is 161.92 and 4.61 as of 22 Jul ‘24

What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Balaxi Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Balaxi Pharmaceuticals Ltd is ₹79.99 and ₹151.45 as of 22 Jul ‘24

What is the CAGR of Balaxi Pharmaceuticals Ltd?

Down Arrow

Balaxi Pharmaceuticals Ltd's CAGR for 5 Years at 47.79%, 3 Years at -6.23%, 1 Year at 2.07%, 6 Month at 22.50%, 3 Month at -7.03% and 1 Month at -14.14%.

What is the shareholding pattern of Balaxi Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Balaxi Pharmaceuticals Ltd is as follows:
Promoters - 66.36 %
Institutions - 17.10 %
Public - 16.54 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.